Publications by authors named "Muhan Yu"

Claim this Profile
O
Open chromatin-guided interpretable machine learning reveals cancer-specific chromatin features in cell-free DNA.
Sakuntha D Gunarathna, Aerica Nagornyuk, Nazim A Belabbaci, Regina Nguyen, Bappa Ghosh, Muhan Yu

Commun Biol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells.
Yu-Chia Chen, Mamoru Takada, Aerica Nagornyuk, Muhan Yu, Hideyuki Yamada, Masayuki Ohtsuka

Elife· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells.
Yu-Chia Chen, Mamoru Takada, Aerica Nagornyuk, Muhan Yu, Hideyuki Yamada, Masayuki Ohtsuka

bioRxiv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cells.
Hideyuki Yamada, Mamoru Takada, Dhaval Ghone, Muhan Yu, Takeshi Nagashima, Masayuki Otsuka

Sci Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cells.
Hideyuki Yamada, Mamoru Takada, Dhaval Ghone, Muhan Yu, Takeshi Nagashima, Masayuki Otsuka

Res Sq· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine.
Hanli Xu, Shuye Lin, Ziyun Zhou, Duoduo Li, Xiting Zhang, Muhan Yu

Cell Mol Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Less necessity of adjuvant S-1 treatment in non-monarchE-eligible patients.
Muhan Yu, Mamoru Takada, Hideyuki Yamada, Hiroshi Fujimoto, Junta Sakakibara, Masayuki Ohtsuka

Cancer Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis